Pure Encapsulations and Cleveland HeartLab, Inc Create The PureHeart™ Protocol

Posted February 14, 2013

A Complementary Collaboration to Deliver Advanced Cardiometabolic Solutions

FEBRUARY 14, 2013 Sudbury, MA- Valentine’s Day may only come once a year, but heart health is an every day concern. One supplement provider has created an initiative to promote proactive heart health and spread the love year-round. Pure Encapsulations, leading manufacturer of research-based, hypo-allergenic nutritional supplements is proud to announce their collaboration with Cleveland HeartLab, Inc., to introduce a breakthrough in preventative cardiometabolic care: The PureHeart™ Protocol: Screening + Supplements = Success.™ This initiative aligns Pure Encapsulations’ innovative, cardiometabolic supplements with advanced biomarker tests developed by Cleveland HeartLab, Inc.

“The PureHeart™ Protocol aligns two equally committed complimentary healthcare systems with a mutual goal of fostering the advancement of cardiometabolic care,” says Joy Devins, VP Business Development, Pure Encapsulations. “We hope to maximize the role that advanced screening and supplements can play in promoting superior heart health, giving patients and doctors the integrative tools they need to remain proactive.”*

The PureHeart™ Protocol cardiometabolic biomarker profile, developed by The Cleveland HeartLaban established leader in the cardiometabolic testing arenaconsists of six unique tests that measure various activities within the arterial wall. These six advanced biomarker tests aim to go beyond routine lipid screening in preventative cardiovascular assessment and further the science and management of vascular and metabolic health. The six biomarker tests include:

Myeloperoxidase (MPO) – Vascular specific marker of arterial health
Lipoprotein-Associated Phospholipase A₂ (LP-PLA₂) Vascular specific marker of lipid balance and arterial health
High Sensitivity C-Reactive Protein (hsCRP) General marker of cardiovascular health
Urinary Microalbumin/Creatinine Ratio Marker of endothelial health
Oxidized LDL (OxLDL) Marker of lipoprotein health
F₂-Isoprostanes/Creatinine Ratio (F₂-IsoPs) General marker of oxidative stress

“At the Cleveland HeartLab we are enthusiastic about our new collaboration with Pure Encapsulations and The PureHeart™ Protocol,” says Jake Orville, Cleveland HeartLab President and Chief Executive Officer. “Together we will be able to progress the importance of advanced biomarker testing that goes beyond lipid testing alone.”

Qualified medical professionals nationwide can incorporate these biomarker tests from Cleveland HeartLab into their practice. Following the screening results and determining the patient’s cardiometabolic profile, Pure Encapsulations PureHeart™ supplements can be recommended as part of ongoing patient care.*

Pure Encapsulations specializes in product innovations for evidence-based supplement support. This includes a commitment to the ongoing research and development of proprietary polyphenol blends with the Institute of Nutraceuticals and Functional Foods (INAF), which has led to a growing platform of options to support the full cardiometabolic spectrum.*

Pure Encapsulations cardiometabolic supplements include ingredients from well-researched categories, including: Ultra-pure omega-3 fish oil; Sustained-release, enhanced absorption coenzyme Q₁₀, resveratrol, and curcumin; Proprietary polyphenol and antioxidant blends.*

“The PureHeart™ Protocol embodies our commitment to applied nutrition science research,” said Dr. Barry W. Ritz, VP Scientific and Regulatory Affairs, Atrium Innovations, the parent company of Pure Encapsulations. “Through this collaboration with the prestigious Cleveland Heart Lab and our own comprehensive research program on the role of nutrition in cardiometabolic health outcomes, we are delivering practical, science-based solutions to health care practitioners and their patients.”*

For more information, or to request a copy of The PureHeart™ Protocol: Screening + Supplements = Success™ brochure, please contact Bryanna Charbonneau at [email protected] or visitwww.PureEncapsulations.com.

About Pure Encapsulations
Pure Encapsulations is committed to producing the most complete line of science-based nutritional supplements. Available through health professionals, finished products are pure and hypo-allergenic to best optimize the long-term health of the most sensitive patients.* Pure Encapsulations is an industry leader in quality, with an extensive raw material and finished product testing program that includes analysis for identity, potency, environmental contaminants, oxidation and more by certified third party laboratories. Pure Encapsulations manufactures its own products in an FDA-inspected, NSF-GMP registered facility, certified in Canada, and exceeds the standards of the United States Pharmacopeia (USP) for supplement manufacturing. For additional information, please visitwww.PureEncapsulations.com.

About Cleveland HeartLab
Cleveland HeartLab Inc., is a CAP-accredited and CLIA-certified clinical reference laboratory that provides novel and affordable testing developed at the world-renowned Cleveland Clinic. Cleveland HeartLab is an established leader in the cardiometabolic testing arena and offers proprietary testing such as Myeloperoxidase (MPO) that examines the health and integrity of the artery wall. This testing expands the scope of cardiovascular assessment beyond standard lipid panels. For educations resources and more details about Cleveland HeartLab’s biomarker testing, visitwww.clevelandheartlab.com.

http://www.youtube.com/watch?feature=player_embedded&v=lD_ge_aa9ZU

See the video